AIM: To enumerate and characterize multipotential stromal cells (MSCs) in a cellular bone allograft and compare with fresh age-matched iliac crest bone and bone marrow (BM) aspirate. MATERIALS & METHODS: MSC characterization used functional assays, confocal/scanning electron microscopy and whole-genome microarrays. Resident MSCs were enumerated by flow cytometry following enzymatic extraction. RESULTS: Allograft material contained live osteocytes and proliferative bone-lining cells defined as MSCs by phenotypic and functional capacities. Without cultivation/expansion, the allograft displayed an 'osteoinductive' molecular signature and the presence of CD45(-)CD271(+)CD73(+)CD90(+)CD105(+) MSCs; with a purity over 100-fold that of iliac crest bone. In comparison with BM, MSC numbers enzymatically released from 1 g of cellular allograft were equivalent to approximately 45 ml of BM aspirate. CONCLUSION: Cellular allograft bone represents a unique nonimmune material rich in MSCs and osteocytes. This osteoinductive graft represents an attractive alternative to autograft bone or composite/synthetic grafts in orthopedics and broader regenerative medicine settings.
AIM: To enumerate and characterize multipotential stromal cells (MSCs) in a cellular bone allograft and compare with fresh age-matched iliac crest bone and bone marrow (BM) aspirate. MATERIALS & METHODS:MSC characterization used functional assays, confocal/scanning electron microscopy and whole-genome microarrays. Resident MSCs were enumerated by flow cytometry following enzymatic extraction. RESULTS: Allograft material contained live osteocytes and proliferative bone-lining cells defined as MSCs by phenotypic and functional capacities. Without cultivation/expansion, the allograft displayed an 'osteoinductive' molecular signature and the presence of CD45(-)CD271(+)CD73(+)CD90(+)CD105(+) MSCs; with a purity over 100-fold that of iliac crest bone. In comparison with BM, MSC numbers enzymatically released from 1 g of cellular allograft were equivalent to approximately 45 ml of BM aspirate. CONCLUSION: Cellular allograft bone represents a unique nonimmune material rich in MSCs and osteocytes. This osteoinductive graft represents an attractive alternative to autograft bone or composite/synthetic grafts in orthopedics and broader regenerative medicine settings.
Entities:
Keywords:
bone marrow; cellular allograft; multipotential stromal cells; osteocytes
Authors: Venkata Lokesh Battula; Sabrina Treml; Petra M Bareiss; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring Journal: Haematologica Date: 2008-12-09 Impact factor: 9.941
Authors: P Kasten; I Beyen; M Egermann; A J Suda; A A Moghaddam; G Zimmermann; R Luginbühl Journal: Eur Cell Mater Date: 2008-10-23 Impact factor: 3.942
Authors: George Cox; Sally A Boxall; Peter V Giannoudis; Conor T Buckley; Tarek Roshdy; Sarah M Churchman; Dennis McGonagle; Elena Jones Journal: Bone Date: 2011-07-23 Impact factor: 4.398
Authors: David B Musante; Michael E Firtha; Brent L Atkinson; Rebekah Hahn; James T Ryaby; Raymond J Linovitz Journal: J Orthop Surg Res Date: 2016-05-27 Impact factor: 2.359
Authors: T Mark Campbell; Sarah M Churchman; Alejandro Gomez; Dennis McGonagle; Philip G Conaghan; Frederique Ponchel; Elena Jones Journal: Arthritis Rheumatol Date: 2016-07 Impact factor: 10.995
Authors: Kavitha Sivasubramaniyan; Dragos C Ilas; Abhishek Harichandan; Pieter K Bos; Diego L Santos; Peter de Zwart; Wendy J L M Koevoet; Heather Owston; Hans-Jörg Bühring; Elena Jones; Gerjo J V M van Osch Journal: Am J Sports Med Date: 2018-11-12 Impact factor: 6.202
Authors: Yasser M El-Sherbiny; Jehan J El-Jawhari; Timothy A Moseley; Dennis McGonagle; Elena Jones Journal: Sci Rep Date: 2018-09-10 Impact factor: 4.379